ArticleSurgical neurology international2025
Ventriculoperitoneal shunt outcomes in neurodegenerative normal pressure hydrocephalus: A case series of 29 patients.
Article in Surgical neurology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Management of normal pressure hydrocephalus (NPH) can be complicated by the progression of underlying neurological conditions such as Alzheimer's disease or Parkinson's disease. The purpose of this study is to explore the long-term shunting response on gait dysfunction in patients with neurodegenerative NPH, a subtype of NPH occurring in patients with another neurodegenerative condition, as the duration of symptomatic improvement with shunting is unclear in this population. Methods: A retrospective chart review of patients undergoing evaluation for NPH at the Adult Hydrocephalus Center at Allegheny General Hospital was performed. Timed performances on two gait measures, the timed walk and timed up and go, were collected during a 2-day outpatient lumbar tap trial and on follow-up evaluation after shunt placement. Improvements over baseline were calculated at each follow-up and analyzed by years after shunt surgery. Potential sequelae of VPS such as subdural hematomas and infection during the study period were tallied. Results: Patients experienced statistically and clinically significant gait improvements within the first 6 months after surgery. Significant reductions in gait times were not found by the end of the 1 Conclusion: While VPS can provide a limited period of improved gait, it was not shown that shunting can provide persisting benefit in patients with underlying progressive neurodegenerative disease. Shunting to alleviate gait symptoms should be considered on a case-by-case basis with patients and their families in alignment with care goals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.